Protected PCI

Procedure

Protected PCI Enables Safe and Effective Treatment of High-Risk and Complex Patients

Benefits of Protected PCI include:

Improved outcomes through complete revascularization and reduction of repeat and staged procedures⁵
Improvement in ejection fraction and heart failure symptoms¹
Significant reduction in the overall incidence of post-procedural acute kidney injury (AKI)²
Fewer hypotensive events during the procedure¹
Reduction in peri-procedural MI and post-procedural MACCE³
Treatment options for patients ineligible for surgery⁴
Reduction in length of stay⁶

Resources

White icon of a book with a arrow pointing down

Read more about the procedural steps for the single-access technique that enables one access site for both the Impella CP® and an additional catheter.

Download PDF

Ejection Fraction Improvement with Complete Revascularization

Mitul Patel, MD, FACC, FSCAI, from UC San Diego (UCSD), discusses the RESTORE EF study and a successful patient case from the study. The case was a 61-year-old male with diabetes, hypertension and hyperlipidemia who had new-onset heart failure and severe three-vessel coronary artery disease (CAD).

Learn More

Resources from the Education Library

Complete Revascularization Associated with Significant Improvement in LVEF and Long-Term Survival

This retrospective study was done at two centers in Rome and Verona, Italy using a prospectively maintained registry database.

Rapid and Safe Adoption of the New Single Access Technique

Duane Pinto, MD, MPH, discusses the new single access technique, designed to avoid an additional arterial access and reduce associated complications as well as make the procedure more rapid.

Complex Percutaneous Axillary Protected PCI Case

Watch Thom Dahle, MD, perform a high-risk PCI procedure recorded live from St. Cloud, MN, with panel commentary.

Image of a physician using a tablet with a blue hash pattern overlay

Abiomed Academy provides self-guided online product training for health care professionals of all experience levels and roles.

Patient Management

References

O’Neill, W.W., et al. (2012). Circulation, 126(14), 1717-1727.
Flaherty, M.P., et al. (2017). Circ Res, 120(4), 692-700.
Dangas, G.D., et al. (2014). Am J Cardiol, 113(2), 222-228.
Waldo, S.W., et al. (2014). Circulation, 130(25), 2295-2301.
Burzotta, F., et al. (2019). J Interv Cardiol, 2019(5), 1-10.
Maini, B., et al. (2014). Expert Rev Pharmacoecon Outcomes Res, 14(3), 403-416.

NPS-1182